These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 30773073)

  • 21. Update on the management of venous thromboembolism.
    Bartholomew JR
    Cleve Clin J Med; 2017 Dec; 84(12 Suppl 3):39-46. PubMed ID: 29257737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism: A Prospective Cohort Study of 12 Patients.
    Christen JR; Bertolino J; Jean E; Camoin L; Ebbo M; Harlé JR; Schleinitz N; Sarlon G; Bernit E
    Hemoglobin; 2019; 43(4-5):296-299. PubMed ID: 31724442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sickle Cell Disease: A Paradigm for Venous Thrombosis Pathophysiology.
    Lizarralde-Iragorri MA; Shet AS
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sickle cell disease: an inherited thrombophilia.
    Wun T; Brunson A
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):640-647. PubMed ID: 27913540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of venous thromboembolism and its associations in a large racially homogenous population of sickle cell disease patients.
    Okoye HC; Ezekekwu C; Nwagha TU; Korubo K; Omunakwe HE; Nnachi OC; Madu AJ; Nwogoh B; Efobi CC; Muoghalu EA; Nonyelu C; Okoye AE; Obodo OI; Ugwu CS; Egolum MC; Nnachi OA; Okpala I
    Eur J Haematol; 2022 Oct; 109(4):321-326. PubMed ID: 35687045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular basis for the prothrombotic state in sickle cell disease.
    Shet AS; Lizarralde-Iragorri MA; Naik RP
    Haematologica; 2020 Oct; 105(10):2368-2379. PubMed ID: 33054077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
    Streiff MB
    J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The five key things you need to know to manage adult patients with sickle cell disease.
    Lanzkron S; Haywood C
    Hematology Am Soc Hematol Educ Program; 2015; 2015():420-5. PubMed ID: 26637752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of rivaroxaban in sickle cell disease and venous thromboembolism: A case report.
    Rozi W; Ali EAH; Al-Mashdali AF; Abdelrazek M; Yassin MA
    Medicine (Baltimore); 2021 Dec; 100(51):e27988. PubMed ID: 34941038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemostatic abnormalities in sickle cell disease.
    Lim MY; Ataga KI; Key NS
    Curr Opin Hematol; 2013 Sep; 20(5):472-7. PubMed ID: 23817169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. THromboprophylaxis In Sickle Cell Disease with central venous catheters (THIS): an internal pilot randomised controlled trial protocol.
    Abdulrehman J; Forté S; Tomlinson G; Solh Z; Bolster L; Sun HL; Bartolucci P; Kuo KHM
    BMJ Open; 2024 Jan; 14(1):e079363. PubMed ID: 38171625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention, diagnosis and treatment of venous thromboembolism.
    Greenall R
    Nurs Older People; 2017 Jan; 29(1):21-25. PubMed ID: 28136021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thromboembolism overview.
    Battinelli EM; Murphy DL; Connors JM
    Hematol Oncol Clin North Am; 2012 Apr; 26(2):345-67, ix. PubMed ID: 22463831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospital acquired venous thromboembolism in children with sickle cell disease.
    Agarwal S; Foster KL; Anum SJ; Shapiro MC; Han H; Scheurer ME; Airewele G; Sartain SE
    Pediatr Hematol Oncol; 2024 Oct; 41(7):459-469. PubMed ID: 38836515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venous thromboembolism in pregnant women with sickle cell disease: a retrospective database analysis.
    Seaman CD; Yabes J; Li J; Moore CG; Ragni MV
    Thromb Res; 2014 Dec; 134(6):1249-52. PubMed ID: 25306185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for venous thromboembolism in adults with hemoglobin SC or Sβ(+) thalassemia genotypes.
    Yu TT; Nelson J; Streiff MB; Lanzkron S; Naik RP
    Thromb Res; 2016 May; 141():35-8. PubMed ID: 26962984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis.
    Noubiap JJ; Temgoua MN; Tankeu R; Tochie JN; Wonkam A; Bigna JJ
    Thromb J; 2018; 16():27. PubMed ID: 30305805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric venous thromboembolism in relation to adults.
    Spentzouris G; Scriven RJ; Lee TK; Labropoulos N
    J Vasc Surg; 2012 Jun; 55(6):1785-93. PubMed ID: 21944920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venous thromboembolism prophylaxis in sickle cell disease: a multicenter cohort study of adolescent inpatients.
    Davila J; Stanek J; O'Brien SH
    Blood Adv; 2023 May; 7(9):1762-1768. PubMed ID: 37103974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.